News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,537 Results
Type
Article (41765)
Company Profile (252)
Press Release (664520)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (205458)
Career Advice (2177)
Deals (35575)
Drug Delivery (97)
Drug Development (81648)
Employer Resources (175)
FDA (16340)
Job Trends (14989)
News (347572)
Policy (32809)
Tag
Academia (2617)
Accelerated approval (6)
Adcomms (21)
Allergies (87)
Alliances (49944)
ALS (97)
Alzheimer's disease (1398)
Antibody-drug conjugate (ADC) (133)
Approvals (16331)
Artificial intelligence (270)
Autoimmune disease (24)
Automation (16)
Bankruptcy (361)
Best Places to Work (11733)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (180)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (292)
Cancer (2330)
Cardiovascular disease (180)
Career advice (1817)
Career pathing (32)
CAR-T (155)
Cell therapy (435)
Cervical cancer (20)
Clinical research (66463)
Collaboration (860)
Company closure (2)
Compensation (557)
Complete response letters (20)
COVID-19 (2627)
CRISPR (42)
C-suite (250)
Cystic fibrosis (101)
Data (2302)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (276)
Diagnostics (6471)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87123)
Editorial (40)
Employer branding (22)
Employer resources (150)
Events (113265)
Executive appointments (745)
FDA (17711)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (777)
Gene editing (111)
Generative AI (21)
Gene therapy (317)
GLP-1 (730)
Government (4473)
Grass and pollen (4)
Guidances (150)
Healthcare (19055)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (124)
Indications (29)
Infectious disease (2771)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (355)
IPO (16558)
IRA (40)
Job creations (3662)
Job search strategy (1535)
Kidney cancer (11)
Labor market (43)
Layoffs (482)
Leadership (20)
Legal (7961)
Liver cancer (76)
Lung cancer (328)
Lymphoma (156)
Machine learning (9)
Management (60)
Manufacturing (328)
MASH (73)
Medical device (13512)
Medtech (13517)
Mergers & acquisitions (19588)
Metabolic disorders (707)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (96)
Neuropsychiatric disorders (27)
Neuroscience (1954)
NextGen: Class of 2025 (6622)
Non-profit (4545)
Now hiring (40)
Obesity (374)
Opinion (213)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (89)
Parkinson's disease (151)
Partnered (21)
Patents (243)
Patient recruitment (116)
Peanut (47)
People (57777)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20720)
Phase II (29275)
Phase III (21791)
Pipeline (1351)
Policy (147)
Postmarket research (2582)
Preclinical (8871)
Press Release (66)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (249)
Rare diseases (385)
Real estate (5961)
Recruiting (66)
Regulatory (22511)
Reports (47)
Research institute (2381)
Resumes & cover letters (367)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (132)
Series B (89)
Service/supplier (11)
Sickle cell disease (52)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3628)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (49)
The Weekly (30)
Vaccines (709)
Venture capitalists (42)
Weight loss (239)
Women's health (36)
Worklife (17)
Date
Today (160)
Last 7 days (931)
Last 30 days (3096)
Last 365 days (32647)
2025 (11742)
2024 (35455)
2023 (40370)
2022 (51523)
2021 (56085)
2020 (54530)
2019 (47089)
2018 (35438)
2017 (32467)
2016 (31902)
2015 (37986)
2014 (31654)
2013 (26710)
2012 (28921)
2011 (29557)
2010 (27603)
Location
Africa (745)
Alabama (54)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38329)
Australia (6328)
California (6386)
Canada (2065)
China (533)
Colorado (274)
Connecticut (280)
Delaware (157)
Europe (82909)
Florida (952)
Georgia (213)
Idaho (58)
Illinois (552)
India (25)
Indiana (321)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (927)
Massachusetts (4755)
Michigan (223)
Minnesota (403)
Mississippi (2)
Missouri (82)
Montana (28)
Nebraska (25)
Nevada (67)
New Hampshire (64)
New Jersey (1786)
New Mexico (30)
New York (1805)
North Carolina (996)
North Dakota (8)
Northern California (2807)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1419)
Puerto Rico (13)
Rhode Island (33)
South America (1121)
South Carolina (25)
South Dakota (1)
Southern California (2405)
Tennessee (106)
Texas (948)
United States (23980)
Utah (188)
Virginia (152)
Washington D.C. (64)
Washington State (567)
West Virginia (3)
Wisconsin (56)
706,537 Results for "trace ability inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
May 2, 2025
·
7 min read
Press Releases
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
November 12, 2024
·
5 min read
Press Releases
Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity
October 1, 2024
·
3 min read
Press Releases
Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies
April 29, 2025
·
4 min read
BioMidwest
Trace Genomics Raises Oversubscribed $10.5 Million Series B, Expanding Reach of Pioneering DNA Soil Intelligence Platform
Trace Genomics, the industry leader in DNA-based soil intelligence, announced its successful Series B funding round at $10.5 million led by existing investors S2G Ventures and Ajax Strategies, as well as new investor Rabo Ventures.
February 20, 2024
·
4 min read
Press Releases
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
April 28, 2025
·
12 min read
Business
Trace Medical & Outset Medical sign long-term distribution agreement for Tablo® Hemodialysis System
Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical to rent the Tablo® Hemodialysis System to Home Medical Equipment (HME) providers.
October 3, 2023
·
4 min read
Pharm Country
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
RespireRx Pharmaceuticals Inc. is pleased to announce that, as part of an ongoing collaboration, a scientist team led by Dr. David Fuller of the University of Florida has published a peer-reviewed research article describing the ability of CX1739.
March 20, 2024
·
14 min read
1 of 70,654
Next
